BioNxt Solutions Completes Oversubscribed Convertible Debenture Offering

BioNxt Solutions Inc. has finalized its oversubscribed private placement, raising $1,250,400 in total. The closing of the final tranche resulted in gross proceeds of $241,200 and the issuance of 402,000 warrants. The offering comprised 8.0% unsecured convertible debenture units for each $0.60 unit, paired with one common share purchase warrant at $0.75 per share, valid for two years.

The funding will support BioNxt’s product development, IP filings, and general working capital. Additionally, a finder’s fee of $19,296 and 32,160 finder’s warrants were issued to Canaccord Genuity Corp. The securities are subject to a hold period until December 9, 2025, under Canadian law.